Walaa Shabana

Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot

Ahmed Abdel‐Razik, Nasser Mousa, Walaa Shabana et al. · European Journal of Gastroenterology & Hepatology · 2018 · 90 citations

<i>Helicobacter pylori</i> and non‐alcoholic fatty liver disease: A new enigma?

Ahmed Abdel‐Razik, Nasser Mousa, Walaa Shabana et al. · Helicobacter · 2018 · 75 citations

A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients

Ahmed Abdel‐Razik, Nasser Mousa, Walaa Shabana et al. · European Journal of Gastroenterology & Hepatology · 2015 · 66 citations

Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy

Ahmed Abdel Khalek Abdel Razek, Lamiaa El-Serougy, Gehad A. Saleh et al. · Diagnostic and Interventional Imaging · 2020 · 45 citations

Locoregional Therapy, Nuclear Medicine, Hepatology +8

Impact of non-alcoholic fatty liver disease on pregnancy

Nasser Mousa, Ahmed Abdel‐Razik, Maher Shams et al. · British Journal of Biomedical Science · 2018 · 34 citations

Metabolic Disorder, Gynecology, Pathology +19